Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Free Cash FlowNet Cash FlowOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

RAPT Therapeutics (RAPT) Depreciation & Amortization (CF): 2018-2024

Historic Depreciation & Amortization (CF) for Therapeutics (RAPT) over the last 7 years, with Dec 2024 value amounting to $1.2 million.

  • Therapeutics' Depreciation & Amortization (CF) fell 9.18% to $287,000 in Q4 2024 from the same period last year, while for Dec 2024 it was $1.2 million, marking a year-over-year decrease of 1.23%. This contributed to the annual value of $1.2 million for FY2024, which is 1.07% down from last year.
  • According to the latest figures from FY2024, Therapeutics' Depreciation & Amortization (CF) is $1.2 million, which was down 1.07% from $1.2 million recorded in FY2023.
  • Therapeutics' 5-year Depreciation & Amortization (CF) high stood at $1.2 million for FY2023, and its period low was $1.0 million during FY2021.
  • In the last 3 years, Therapeutics' Depreciation & Amortization (CF) had a median value of $1.2 million in 2024 and averaged $1.2 million.
  • Per our database at Business Quant, Therapeutics' Depreciation & Amortization (CF) dropped by 15.56% in 2020 and then increased by 16.14% in 2023.
  • Therapeutics' Depreciation & Amortization (CF) (Yearly) stood at $1.1 million in 2020, then dropped by 10.95% to $1.0 million in 2021, then climbed by 4.70% to $1.0 million in 2022, then grew by 16.14% to $1.2 million in 2023, then dropped by 1.07% to $1.2 million in 2024.